Daniel Sabater‐Hernández

2.1k total citations · 1 hit paper
56 papers, 1.4k citations indexed

About

Daniel Sabater‐Hernández is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and General Health Professions. According to data from OpenAlex, Daniel Sabater‐Hernández has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Geriatrics and Gerontology, 19 papers in Cardiology and Cardiovascular Medicine and 18 papers in General Health Professions. Recurrent topics in Daniel Sabater‐Hernández's work include Pharmaceutical Practices and Patient Outcomes (35 papers), Blood Pressure and Hypertension Studies (19 papers) and Health Policy Implementation Science (15 papers). Daniel Sabater‐Hernández is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (35 papers), Blood Pressure and Hypertension Studies (19 papers) and Health Policy Implementation Science (15 papers). Daniel Sabater‐Hernández collaborates with scholars based in Spain, Australia and Portugal. Daniel Sabater‐Hernández's co-authors include Shalom I. Benrimoj, Joanna C. Moullin, Fernando Fernández-Llimós, Fernando Martínez‐Martínez, María José Faus, Lucía Franco-Trigo, Victoria García‐Cárdenas, Patricia Kenny, María José Faus and Loreto Sáez‐Benito and has published in prestigious journals such as SHILAP Revista de lepidopterología, Patient Education and Counseling and BMJ Open.

In The Last Decade

Daniel Sabater‐Hernández

52 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework

2015 248 citations Joanna C. Moullin, Daniel Sabater‐Hernández et al. profile →

Peers

Daniel Sabater‐Hernández

GHP

CCM

Linda MacKeigan Canada

Michelle A. Chui United States

Lisa McCarthy Canada

Neil Cottrell Australia

Lisa M. Guirguis Canada

Fernando Martínez‐Martínez Spain

Chima D. Ndumele United States

Teresa M. Salgado United States

Jo‐anne E Brien Australia

June Tordoff New Zealand

Linda MacKeigan Canada

Daniel Sabater‐Hernández

586 ×0.8

476 ×0.8

GHP

287 ×1.1

327 ×1.5

156 ×0.7

CCM

Citations per year, relative to Daniel Sabater‐Hernández Daniel Sabater‐Hernández (= 1×) peers Linda MacKeigan

Countries citing papers authored by Daniel Sabater‐Hernández

Since Specialization

Citations

This map shows the geographic impact of Daniel Sabater‐Hernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Sabater‐Hernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Sabater‐Hernández more than expected).

Fields of papers citing papers by Daniel Sabater‐Hernández

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Sabater‐Hernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Sabater‐Hernández. The network helps show where Daniel Sabater‐Hernández may publish in the future.

Co-authorship network of co-authors of Daniel Sabater‐Hernández

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Sabater‐Hernández. A scholar is included among the top collaborators of Daniel Sabater‐Hernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Sabater‐Hernández. Daniel Sabater‐Hernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernández-Llimós, Fernando, Tim Luckett, Joanna C. Moullin, et al.. (2017). Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners. BMJ Open. 7(9). e015471–e015471. 53 indexed citations

Moullin, Joanna C., Daniel Sabater‐Hernández, & Shalom I. Benrimoj. (2016). Qualitative study on the implementation of professional pharmacy services in Australian community pharmacies using framework analysis. BMC Health Services Research. 16(1). 439–439. 84 indexed citations

Jódar‐Sánchez, Francisco, Amaia Malet‐Larrea, José Jesús Martín Martín, et al.. (2015). Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program. PharmacoEconomics. 33(6). 599–610. 85 indexed citations

Sabater‐Hernández, Daniel, et al.. (2015). Identifying masked uncontrolled hypertension in the community pharmacy setting. Blood Pressure Monitoring. 20(3). 138–143. 3 indexed citations

Moullin, Joanna C., Daniel Sabater‐Hernández, & Shalom I. Benrimoj. (2015). Model for the evaluation of implementation programs and professional pharmacy services. Research in Social and Administrative Pharmacy. 12(3). 515–522. 55 indexed citations

Jódar‐Sánchez, Francisco, Amaia Malet‐Larrea, José Jesús Martín Martín, et al.. (2014). Cost-Utility Analysis of A Medication Review With Follow-Up for Older People With Polypharmacy in Community Pharmacies in Spain: Consigue Program. Value in Health. 17(7). A511–A512. 1 indexed citations

García‐Cárdenas, Victoria, Daniel Sabater‐Hernández, Patricia Kenny, et al.. (2013). Effect of a pharmacist intervention on asthma control. A cluster randomised trial. Respiratory Medicine. 107(9). 1346–1355. 105 indexed citations

Sabater‐Hernández, Daniel, et al.. (2013). Validación clínica de los dispositivos de medida de la presión arterial y recomendaciones para su elección: curso "Servicio de atención farmacéutica. Educación para la salud". Tema 4. 9(95). 16–21.

Amariles, Pedro, Daniel Sabater‐Hernández, & María José Faus. (2012). INVESTIGAR Y PUBLICAR EN ATENCIÓN FARMACÉUTICA: UNA LABOR POR FORTALECER. Revista Vitae. 19(1). 9–11. 1 indexed citations

10.

Martínez, Fernando Martínez, et al.. (2011). Estudio de adecuación a la ficha técnica de las prescripciones de trastuzumab en un hospital de tercer nivel. Farmacia Hospitalaria. 36(3). 135–140. 3 indexed citations

11.

Sabater‐Hernández, Daniel, et al.. (2011). Agreement Between Community Pharmacy, Physician's Office, and Home Blood Pressure Measurement Methods: The Palmera Study. American Journal of Hypertension. 25(3). 290–296. 16 indexed citations

12.

Sabater‐Hernández, Daniel, et al.. (2011). Comparison of the white-coat effect in community pharmacy versus the physician's office. Blood Pressure Monitoring. 16(2). 62–66. 16 indexed citations

13.

Sabater‐Hernández, Daniel, et al.. (2011). Magnitude of the White-Coat Effect in the Community Pharmacy Setting: The MEPAFAR Study. American Journal of Hypertension. 24(8). 887–892. 18 indexed citations

14.

Sabater‐Hernández, Daniel, et al.. (2011). Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study. International Journal of Clinical Pharmacy. 33(3). 582–589. 6 indexed citations

15.

Sabater‐Hernández, Daniel, et al.. (2011). Evaluation of the hypertensive state in treated patients. Blood Pressure Monitoring. 16(3). 103–110. 9 indexed citations

16.

Sabater‐Hernández, Daniel, et al.. (2007). Método Dáder: guía de seguimiento farmacoterapéutico. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 31 indexed citations

17.

Sabater‐Hernández, Daniel, et al.. (2007). Efecto de una intervención farmacéutica en los parámetros clínicos de pacientes con síndrome metabólico: estudio piloto prospectivo "antes-después". 9(2). 73–79.

18.

Dáder, María José Faus, et al.. (2006). Seguimiento farmacoterapéutico y parámetros de efectividad y seguridad de la farmacoterapia. 84–100. 2 indexed citations

19.

Sabater‐Hernández, Daniel, et al.. (2006). Actuación farmacéutica en prevención cardiovascular. 3 indexed citations

20.

Sabater‐Hernández, Daniel, et al.. (2005). Cómo mejorar su salud cardiovascular. Institutional Repository of the University of Granada (University of Granada). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact